From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Synonyms: Apretude® | CAB | Cabenuva® (cabotegravir + rilpivirine) | GSK-1265744 | GSK1265744 | GSK744 | Vocabria®
cabotegravir is an approved drug (EMA (2020), FDA (2021))
Compound class:
Synthetic organic
Comment: Cabotegravir (GSK1265744, CAB) is a long-acting HIV integrase inhibitor. It is structurally related to dolutegravir.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Inhibits HIV-1 integrase strand transfer activity using (using [3H]-DNA as substrate ) with an IC50 of 3 nM in vitro [1]. |